Your browser doesn't support javascript.
loading
Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors.
Waqar, Saiama N; Robinson, Clifford; Olszanski, Anthony J; Spira, Alexander; Hackmaster, Melissa; Lucas, Luisa; Sponton, Laura; Jin, Hulin; Hering, Ursula; Cronier, Damien; Grinberg, Marianna; Seithel-Keuth, Annick; Diaz-Padilla, Ivan; Berlin, Jordan.
Afiliación
  • Waqar SN; Division of Oncology, Washington University School of Medicine and Alvin J. Siteman Cancer Center, Saint Louis, MO, USA.
  • Robinson C; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, MO, USA.
  • Olszanski AJ; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, MO, USA.
  • Spira A; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Hackmaster M; Medical Oncology, Virginia Cancer Specialists Research Institute and US Oncology Research, Fairfax, VA, USA.
  • Lucas L; Medical Oncology, Virginia Cancer Specialists Research Institute and US Oncology Research, Fairfax, VA, USA.
  • Sponton L; Merck S.L.U, Mollet del Valles, Spain, an affiliate of Merck KGaA, Darmstadt, Germany.
  • Jin H; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Hering U; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Cronier D; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Grinberg M; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Seithel-Keuth A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Diaz-Padilla I; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Berlin J; Oncology Global Clinical Development, Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany.
Invest New Drugs ; 40(3): 679, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35226229

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos